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Enantioselective Insertion of Carbenoids into N-H Bonds Catalyzed by  
Chiral Bicyclo Bisoxazoline Copper(I) Complexes. 
Paul Le Maux* and Gérard Simonneaux*
Institut des Sciences Chimiques de Rennes, UMR CNRS 6226, Ingénierie Chimique et 
Molécules pour le Vivant, Campus de Beaulieu, 35042 Rennes Cedex, France 
Abstract 
Chiral copper(I)-bicyclobisoxazoline complexes were found to catalyse the insertion of Į-
diazocarbonyl compounds into N-H bonds of aniline derivatives. The insertion reactions 
proceeded with high yields (78-99%) and enantioselectivities of up to 81% for the different Į-
diazopropionates. A predominant effect of the nature and the position of the substituents on 
the enantiocontrol of the reaction was observed. 
  
Keywords: N-H insertion catalysis; Copper; Chiral bisoxazoline ; Enantioselectivity. 
* Corresponding author. E-mail address: paul.lemaux@univ-rennes1.fr (P. Le Maux). 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT

Ϯ

1. Introduction
 The transition-metal-catalyzed insertion of carbenoid species derived from Į-
diazocarbonyl compounds into X-H bonds (X = C, N, O, S, Si, etc.) has been widely 
recognized as a direct and efficient method for the construction of carbon-carbon and carbon-
heteroatom bonds.1-6 Among the insertion reactions, metal-catalyzed N-H insertions are of 
great importance, because they lead to the formation of various bioactive molecules such as Į-
amino acid derivatives, Į-amino ketones, and pharmaceutically useful compounds.7-16 The 
earliest example of an asymmetric N-H insertion is the chiral auxiliary approach of Kagan 
who developed a diastereoselective CuCN-catalyzed reaction with chiral amines or chiral 
diazoester acetates resulting in up to 26% de.17 The first significant progress was realized in 
1996 by McKervey in an intramolecular N-H insertion reaction, catalyzed by chiral rhodium 
(II) carboxylates leading to pipecolic acid derivatives with up to 45% ee.18 Jørgensen and 
coworkers reported the first asymmetric intermolecular N-H insertion reactions by means of 
chiral copper(I)/silver(I) bisoxazoline.19 Although only low to moderate yields and ee values 
were obtained, this study has actually opened the doors to new developments in the area of 
asymmetric N-H insertion reactions with copper. Chiral rhodium complexes can also be good 
catalysts for such reaction but the facility with which rhodium carbenoids undergo C-H 
insertion20 and ȕ-elimination21 remains a problem with certain substrates. Since then 
developments with copper(I) have been rapid and high enantioselectivities have been 
achieved.22-24 Zhou and coworkers22  reported excellent ee values (98%) and yield (96%) 
using a catalytic system consisting of a spirobisoxazoline ligand, CuCl, and NaBARF (BARF 
= [B[3,5-(CF3)2C6H3]4]-) in the insertion of MeC(N2)CO2R into aniline derivatives. Other 
chiral bisoxazolines with different backbones, such as Box, Pybox, and Binabox exhibited 
low enantioselectivity (0-12% ee).5 This clearly demonstrates in these studies that the chiral 
spirobiindane structure of bisoxazoline was essential for obtaining high enantioselectivity in 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT

ϯ

Cu-catalyzed asymmetric N-H insertion reaction. Two other systems, using Cu(I) complexes 
of bis (azaferrocene) and binol derivatives as catalysts, have also been developed,  they 
exhibited excellent enantioselectivities (up to 98%).15,25  
 In view of the great utility of this N-H insertion reaction, the exploration of alternative 
efficient catalytic system is still desirable.  Our group has first demonstrated that ruthenium 
porphyrin complexes catalyze the ethyl diazoacetate insertion into N-H and S-H bonds in 
1997.26,27 Recently, we reported the application of a bisoxazoline ligand (Fig. 1), previously 
introduced by Takacs et al.28 for the asymmetric copper-catalyzed Diels-Alder reaction.29
Herein, we describe a readily available copper(I) catalytic system generated from 
bisoxazoline ligands bearing a chiral dihydroethanoanthracene backbone (L*) (Fig. 1) and 
CuOTf for asymmetric N-H insertion of Į-alkyl-Į-diazoesters with aniline derivatives. 

Fig.1. Structures of the chiral bicyclobisoxazoline ligands. 
2. Results and discussion
  Studies realized on the copper-catalyzed asymmetric N-H insertion of ethyl Į-
diazopropionate with aniline have demonstrated that the enantioselectivity was directly 
related to the anion of the copper precursor.19,22 The smaller and stronger coordinating anions 
were found to be inferior to the larger and weaker coordinating anions for chiral induction. On 
this basis, various copper catalyst precursors were tested with different counterions (OTf-, 
BARF-, PF6-). We can see in Table 1 that the nature of the counterion had a significant effect 
on the enantioselectivity. The catalytic system with the smaller and stronger coordinating 
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OTf- was the most efficient in the N-H insertion reaction of o-chloraniline with ethyl Į-
diazopropionate, 77% ee (entry 1). The weakly coordinating PF6- gave the insertion product in 
only 22% ee (entry 2), while with the larger and non-coordinating ion BARF- the 
enantioselectivity was in the range of 54-57% ee (entries 3 and 4). These results are in 
contrast with those reported by Zhou where excellent ee values (up to 98%) were obtained 
using a catalytic system consisting of a spirobisoxazoline ligand, CuCl, and NaBARF, but 
only 5% ee with CuOTf.22  
Table 1. Cu-catalyzed asymmetric insertion of ethyl Į-diazopropionate into N-H bond of o-Cl 
anilinea 
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Entry [Cu] Product Yield (%) Ee (%) 
1 CuOTf (C6H6)1/2 3d 97 77 
2 Cu(CN)4PF6 3d 97 22 
3 Cu(CN)4PF6/NaBARFb 3d 97 57 
4 CuCl/NaBARFb 3d 78 54 
a Reaction conditions: [Cu] (5 μmol) and  ligand  (6 μmol) were mixed in CH2Cl2 
(1 ml) for 1 h at 25°C, then o-Claniline (100 μmol) and ethyl 2-diazopropionate 
 (100 μmol) were introduced and stirred for 1 h at 25°C. b NaBARF (6 μmol). 
  
 With the optimized conditions in hand, our catalytic system has been applied to a 
variety of substituted anilines. The N-H insertion reaction of different alkyl-Į-diazoester 
compounds in the presence of catalysts derived from the chiral ligand bicyclobisoxazoline 
(L*) and Cu(I) triflate was investigated. As shown in Table 2, the reactions with ethyl and 
benzyl Į-diazopropionate afforded the corresponding insertion products in one hour with high 
yields (>95%) and in the range of 78-81% with t-butyl Į-diazopropionate. The presence of 
halogen substituents at the ortho-position of aniline derivatives led to a significant increase in 
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enantioselectivity relative to meta and para-position, probably because of steric hindrance and 
electronic effect. Both effects appear favorable in controlling the enantioselectivity (entries 3, 
4, 5, 19, and 20). The substitution of aniline with the chloro group in the ortho-position gave 
the major improvement of enantioselectivity with ethyl Į-diazopropionate, 46% vs 77% ee 
(entries 1 and 4). No such stereoelectronic effect has already been reported. Zhou had rather 
observed a slightly diminution of the enantioselectivity when a halogen atom was introduced 
in the ortho position of aniline but the enantioselectivity remains high (85-91%).22 The 
enantioselectivity decreased with m-Cl and p-Cl aniline, 66 and 48% ee respectively (entries 8 
and 10). Electron-donor methyl group at the ortho, meta and para-positions afforded lower 
enantioselectivities, 42%, 33% and 31% ee respectively (entries 2, 7 and 9). In order to 
optimize the enantioselectivity of the reaction, the influence of the steric hindrance of ester 
group of diazo compound was examined. The enantioselectivity was increased when the ester
group was changed from ethyl to t-butyl group in the reaction with aniline, ee up to 53% 
(entrie 11), and also with o, m and p-Me aniline, ee up to 56, 44 and 47% respectively (entries 
12, 13 and 14). In contrast, the enantioselectivity decreased with o-Cl aniline to 67 % ee 
(entry 15). The reason for the negative effect of the chloro substituent is unclear. With a 
benzyl group on the diazoester, the highest enantioselectivity was obtained in the reaction 
with o-Cl aniline, 81% ee (entry 19). In the reaction of ethyl Į-phenyl diazoacetate (R1 = Ph) 
with o-Cl aniline, the insertion product was formed in 84% yield and 50% ee (entry 21). From 
observation of these results, the steric bulks of the substituents on the diazoester modify 
weakly the enantioselectivity, compared to the effect of the electron-withdrawing substituent 
in the ortho-position of the aniline. Increase of  the steric bulk by using 1-naphtylamine as the 
substrate, which is a disubstituted aniline, the reaction provided 85% yield and 43% ee (entry 
22). The alkylamines, n-butylamine and t-butylamine (entries 23 and 24) did not react. 
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Table 2. Catalytic asymmetric N-H insertion of amines with Į-diazoestersa
 
Entry R1 R2 R3 Product Yield (%) Ee (%) 
1 Me Et C6H5 3a 98       46b
2 Me Et o-MeC6H4 3b 97 42 
3 Me Et o-FC6H4 3c 98 72 
4 Me Et o-ClC6H4 3d 97 77 
5 Me Et o-BrC6H4 3e 98 74 
6 Me Et o-I C6H4 3f 98 67 
7 Me Et m-MeC6H4 3g 98 33 
8 Me Et m-ClC6H4 3h 98 66 
9 Me Et p-MeC6H4 3i 98 31 
10 Me Et p-ClC6H4 3j 99 48 
11 Me t-Bu C6H5 3k 86 53 
12 Me t-Bu o-MeC6H4 3l 83 56 
13 Me t-Bu m-MeC6H4 3m 78 44 
14 Me t-Bu p-MeC6H4 3n 92 47 
15 Me t-Bu o-ClC6H4 3o 89 67 
16 Me t-Bu m-ClC6H4 3p 88 67 
17 Me t-Bu p-ClC6H4 3q 91 55 
18 Me CH2Ph C6H5 3r 98 52 
19 Me CH2Ph o-ClC6H4 3s 98 81 
20 Me CH2Ph o-BrC6H4 3t 97 73 
21 
22 
23 
24 
Ph 
Me 
Me 
Me 
Et 
Et 
Et 
Et 
o-ClC6H4 
1-Naphtyl 
n-Bu 
t-Bu 
3v 
3w 
3x 
3y 
84 
85 
0 
0 
50 
43 
- 
- 
a Reaction conditions: CuOTf (5 μmol) and  ligand  (6 μmol) were mixed in CH2Cl2  
(1 ml) for 1 h at 25°C, then aniline (100 μmol) and alkyl Į-diazopropionate(100 μmol) 
 were introduced and stirred for 1 h at 25°C. b The absolute configuration (S) of 3a was  
determined by comparison of the optical rotation with the reference.22
 The influence of different substituent groups on the ligand was summarized in Table 3. 
With aniline and o-Cl aniline as substrates, the yields were better with the ligand bearing 
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phenyl susbtituent, 97-98% (entries 1 and 2). The enantioselectivity was improved  from an i-
butyl (48% ee) to t-butyl (69% ee) and phenyl substituents (77% ee) (entries 6, 4 and 2 
respectively) with  o-Cl aniline as substrate. The ee values were lower with aniline. Other 
reaction condition such as excess of ligand did not significantly influence the 
enantioselectivity of the catalyst whereas lower temperature (0°C) decreased the yield and 
enantioselectivity. 
Table 3. Catalytic asymmetric N-H insertion of arylamines with ethyl Į-diazopropionate with 
different ligandsa


ŶƚƌǇ >ŝŐĂŶĚZс Zϭ ZϮ Zϯ WƌŽĚƵĐƚ zŝĞůĚ;йͿ Ğ;йͿ
ϭ WŚ DĞ ƚ C6H5 ϯĂ ϵϴ ϰϲ
Ϯ WŚ DĞ ƚ ŽͲůϲ,ϰ ϯĚ ϵϳ ϳϳ
ϯ ƚͲƵ DĞ ƚ C6H5 ϯĂ ϴϮ ϱϲ
ϰ ƚͲƵ DĞ ƚ ŽͲůϲ,ϰ ϯĚ ϳϱ ϲϵ
ϱ ŝͲƵ DĞ ƚ C6H5 ϯĂ ϴϲ Ϯϯ
ϲ ŝͲƵ DĞ ƚ ŽͲůϲ,ϰ ϯĚ ϳϳ ϰϴ
a Reaction conditions: CuOTf (5 μmol) and  ligand  (6 μmol) were mixed in
CH2Cl2 (1 ml) for 1 h at 25°C, then aniline (100 μmol) and ethyl Į-diazopropionate 
(100 μmol) were introduced and stirred for 1 h at 25°C. 
 In order to obtain information on the reaction mechanism, investigations on the 
catalyst structure were undertaken by electrospray ionization mass spectrometry (ESI-MS) 
analysis. ESI-MS of CuL* prepared in situ from CuOTf and ligand L* revealed the presence 
of two species in solution (m/z 559.1445, [CuL*]+ and m/z 1055.3595, [CuL2*]+). An analogy 
can be made with a previous study with copper complex bearing spirobisoxazoline ligand (L) 
prepared in situ from CuCl and the ligand (L).23 Species of the type [CuL]+ and [CuL2]+ have 
also been detected together with a dimeric species [Cu2Cl(L)2]+. Formation of [CuL2] was 
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related to the fragmentation of the dimer. In our case, only traces of the dimeric species 
[Cu2OTf (L*)2] (0.02%) were present, due to a possible instability in the ESI-MS conditions. 

Fig. 2. ESI-MS analysis of the solution of [CuL*] formed by CuOTf and L*(1:1 molar ratio) 
in CH2Cl2. 
 A generally accepted insertion mechanism includes the formation of an electron-
deficient metal carbene intermediate and the insertion into the N-H bond according to a 
stepwise ylide-generation/proton-shift process (Scheme 1).23 High enantioselectivities can be 
achieved in the metal-associated-ylide pathway (path A) in which the copper complex 
remained bound to the substrate for transfer of chiral information during the proton migration. 
In the free ylide pathway (path B), the chiral catalyst is dissociated and thus low 
enantioselectivities would be obtained. During the experimental process of the reaction 
typical changes in the colour were observed and may offer insight on the mechanism. After 
the addition of o-Cl aniline, the colour of solution turned pale-green to violet, then yellow 
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after the addition of the diazo compound. We suspected that the aniline could coordinate to 
the central metal copper in the catalyst (violet colour), but not too strongly, in order to allow 
the formation of the copper carbene (yellow colour). The electron-deficient copper carbene is 
then attacked by the lone-pair electrons of the aniline nitrogen atom which lead to the metal-
associated-ylide intermediate. With aniline derivatives bearing electron-withdrawing 
substituents, the degeneration of the catalyst-associated-ylide to a free ylide was probably less 
facilitated and thus leads to better enantioselectivity. Moreover, the greater steric hindrance of 
substituent at the ortho-position of aniline might also enhance the chiral induction. 
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Scheme 1. Proposed mechanism for copper-catalyzed N-H insertion 

3. Conclusion 
In summary, we have developed a new Cu(I)-bicyclobisoxazoline-catalyst system for the 
asymmetric insertion of Į-diazocarbonyl compounds into the N-H bond of different 
substituted aniline derivatives under mild conditions. Excellent yields and good 
enantioselectivities of up to 81% can be obtained. Studies of the electronic properties of the 
substrates have demonstrated that electron-withdrawing substituents on the ortho-position of 
aniline gave the best enantioselectivities. In this work, it is clear that the aryl substituent is 
critically important, presumably via a combination of steric and electronic effect. A stepwise 
insertion mechanism involving simultaneous proton transfer and catalyst dissociation as major 
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pathway has been proposed. Studies on the application of the insertion reaction into O-H and 
S-H bond with Cu and Fe-catalyst systems are in progress. 
4. Experimental 
4.1. General 
All reactions were performed under argon. Solvents were distilled from an appropriate drying 
agent prior to use: CH2Cl2 from CaH2. Commercially available reagents were used without 
further purification unless otherwise stated. All reactions were monitored by TLC with Merck 
precoated aluminum foil sheets (Silica gel 60 with fluorescent indicator UV254). Compounds 
were visualized with UV light at 254 nm. Column chromatographies were carried out using 
silica gel from Merck (0.063−0.200 mm). 1H NMR and 13C NMR in CDCl3 were recorded 
using Bruker (Advance 400dpx spectrometer) at 400 MHz and 125 MHz, respectively. High 
resolution mass spectra were recorded on a Thermo-Fisher Q-Exactive spectrometer in ESI 
positif mode at the CRMPO at Rennes. Aromatic amines were commercially available and 
were purified by distillation prior to use. All catalytic reactions were controlled on a Varian 
CP-3380 GC system that was equipped with a CP-Chirasil-Dex Column (25m, 0.25 mm I.D.) 
HPLC analysis was realized on a Varian Prostar 218 system equipped with a Chiralpak AS-H 
or a Chiralcel OJ-H column. The optical rotations were recorded on a PerkinElmer model 341 
polarimeter. The bicyclobis(oxazoline) ligands L* were synthetized as we previously 
described.29 The Į-diazoesters 1 were prepared according to procedures described in the 
literature.19,30,31  
4.2. General procedure for asymmetric N-H insertion reaction 
A mixture of Cu(I)(OTf) (5ȝmol, 5 mol % ) and  ligand  (6 ȝmol,) in dry CH2Cl2 (1 ml) was 
stirred for 1 h at 25°C under argon. The substrate (100 ȝmol) and the Į-diazopropionate (100 
ȝmol) were then respectively added. The solution was stirred at 25°C under the argon 
atmosphere for 1 h and purified by flash chromatography (ethyl acetate/hexane = 0.5/9.5). 
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The insertion yield was determined by GC analysis on the crude reaction mixture and the 
enantiomeric excess of the insertion product was determined by chiral HPLC analysis. 
4.3. Analytical data for N-H insertion products 
4.3.1. (-)-Ethyl-2-(phenylamino)propionate 3a. Yield: 98%; 1H NMR (CDCl3): į = 1.18 (t, 
3H), 1.39 (d, 3H), 4.05 (q, 1H),  4.11 (q, 2H), 6.53 (d, 2H), 6.68 (t, 1H), 7.10 (t, 2H); 13C 
NMR (CDCl3): 14.22, 18.96, 52.05, 61.14, 113.44, 118.28, 129.33, 146.64, 174.63; [Į]20D = -
17.6 (c 1.7, CHCl3); ee = 38% (HPLC conditions: Chiralpak AS-H column, hexane/i-PrOH : 
95/5, flow rate = 0.3 ml/min, wavelength = 220 nm, tR =  25.42 min for minor isomer , tR = 
30.02 min for major isomer). HRESIMS (m/z) calculated for C11H16NO2: 194.1175 (M + H)+, 
found: 194.1175. 
4.3.2. (-)-Ethyl-2-(o-toluidino)propionate 3b. Yield: 97%; 1H NMR (CDCl3): į = 1.18 (t, 
3H), 1.43 (d,3H), 2.12 (s, 3H), 4.12 (m, 3H), 6.45 (d, 1H), 6.60 (t, 1H), 7.01 (m, 2H); 13C 
NMR (CDCl3): 14.20, 17.48, 19.15, 52.00, 61.17, 110.34, 117.84, 122.67, 127.08, 130.39, 
144.70, 174.78; [Į]20D = -12.5 (c 2, CHCl3); ee = 42% (GC conditions: CP-Chirasil-Dex 
column, 80°C (1 min), 1°C min-1 80-180°C , tR = 45.66 min for minor isomer , tR = 46.34 min 
for major isomer). HRESIMS (m/z) calculated for C12H18NO2: 208.1332 (M + H)+, found: 
208.1330. 
 4.3.3. (-)-Ethyl-2-(o-fluorophenylamino)propionate 3c. Yield: 98%; 1H NMR (CDCl3): į = 
1.27 (t, 3H), 1.53 (d,3H), 4.16 (q, 1H), 4.22 (q, 2H), 6.63-6.71 (m, 2H), 6.97-7.03 (m, 2H); 
13C NMR (CDCl3): 14.17, 18.86, 51.86, 61.21, 112.73, 114.68, 114.86, 117.71, 117.78, 
124.51, 174.09; [Į]20D = -35.3 (c 1.3, CHCl3); ee = 65% (GC conditions: CP-Chirasil-Dex 
column, 80°C (1 min), 1°C min-1 80-180°C, tR = 36.85 min for minor isomer , tR = 37.92 min 
for major isomer). HRESIMS (m/z) calculated for C11H15NO2F: 212.1081 (M + H)+, found: 
212.1079. 
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 4.3.4. (-)-Ethyl-2-(o-chlorophenylamino)propionate 3d. Yield: 98%; 1H NMR (CDCl3): į
= 1.28 (t, 3H), 1.55 (d,3H), 4.18 (q, 1H), 4.23 (q, 2H), 6.61 (d, 1H), 6.69 (t, 1H), 7.13 (t, 1H), 
7.29 (d, 1H); 13C NMR (CDCl3): 14.17, 18.79, 51.90, 61.29, 111.68, 118.16, 119.74, 127.75, 
129.41, 142.59, 173.87; [Į]20D = -14.5 (c 1.6, CHCl3); ee = 77% (HPLC conditions: Chiralcel 
OD-H column, hexane/i-PrOH : 98/2, flow rate = 1 ml/min, wavelength = 220 nm, tR = 6.30 
min for major isomer , tR = 17.93 min for minor isomer). HRESIMS (m/z) calculated for 
C11H14NO2ClNa: 250.0605 (M + Na)+, found: 250.0608. 
4.3.5. (-)-Ethyl-2-(o-bromophenylamino)propionate 3e. Yield: 87%; 1H NMR (CDCl3): į = 
1.28 (t, 3H), 1.55 (d,3H), 4.19 (q, 1H), 4.23 (q, 2H), 6.58 (d, 1H), 6.62 (t, 1H), 7.17 (t, 1H), 
7.45 (d, 1H); 13C NMR (CDCl3): 14.17, 18.78, 52.05, 61.30, 110.22, 111.70, 118.64, 128.45, 
132.69, 143.62, 173.85; [Į]20D = -1.0 (c 2.5, CHCl3); ee = 75% (HPLC conditions: Chiralcel 
OB-H column, hexane/i-PrOH : 99/1, flow rate = 0.5 ml/min, wavelength = 220 nm, tR =
15.52 min for major isomer , tR = 21.30 min for minor isomer). HRESIMS (m/z) calculated 
for C11H15NO2Br: 272.0286 (M + H)+, found: 272.0290. 
4.3.6. (+)-Ethyl-2-(o-iodophenylamino)propionate 3f. Yield: 82%; 1H NMR (CDCl3): į = 
1.29 (t, 3H), 1.56 (d,3H), 4.18 (q, 1H), 4.23 (q, 2H), 6.50 (t, 1H), 6.52 (d, 1H), 7.21 (t, 1H), 
7.70 (d, 1H); 13C NMR (CDCl3): 14.20, 18.80, 52.41, 61.33, 85.88, 111.02, 119.45, 129.40, 
139.34, 145.95, 173.87; [Į]20D = +7.2 (c 2.9, CHCl3); ee = 55% (HPLC conditions: Chiralcel 
OB-H column, hexane/i-PrOH : 99/1, flow rate = 0.5 ml/min, wavelength = 220 nm, tR =
17.56 min for major isomer , tR = 26.38 min for minor isomer). HRESIMS (m/z) calculated 
for C11H15NO2I: 320.0147 (M + H)+, found: 320.0158. 
4.3.7. (-)-Ethyl-2-(m-toluidino)propionate 3g. Yield: 98%; 1H NMR (CDCl3): į = 1.17 (t, 
3H), 1.38 (d,3H), 2.18 (s, 3H), 4.04 (q, 1H), 4.11 (q, 2H), 6.34 (d, 1H), 6.36 (s, 1H), 6.48 (d, 
1H), 6.98 (t, 1H); 13C NMR (CDCl3): 14.23, 18.98, 21.62, 52.05, 61.10, 110.55, 114.33, 
119.26, 129.18, 139.08, 146.81, 174.84; [Į]20D = -12.7 (c 2.5, CHCl3); ee = 33% (HPLC 
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conditions: Chiralpak AS-H column, hexane/i-PrOH : 99/1, flow rate = 0.3 ml/min, 
wavelength = 220 nm, tR = 23.11 min for minor isomer , tR = 27.40 min for major isomer). 
HRESIMS (m/z) calculated for C12H18NO2: 208.1332 (M + H)+, found: 208.1330. 
4.3.8. (-)-Ethyl-2-(m-chlorophenylamino)propionate 3h. Yield: 98%; 1H NMR (CDCl3): į
= 1.29 (t, 3H), 1.49 (d, 3H), 4.12 (q, 1H),  4.23 (q, 2H), 6.51 (d, 1H), 6.62 (s, 1H), 6.73 (d, 
1H), 7.10 (t, 1H); 13C NMR (CDCl3): 14.19, 18.72, 51.91, 61.34, 111.80, 113.23, 118.26, 
130.29, 135.06, 147.56, 174.05; [Į]20D = -23.7 (c 2.7, CHCl3); ee = 66% (HPLC conditions: 
Chiralpak AS-H column, hexane/i-PrOH : 98/2, flow rate = 0.5 ml/min, wavelength = 220 
nm, tR = 17.13 min for minor isomer , tR = 23.51 min for major isomer). HRESIMS (m/z) 
calculated for C11H15ClNO2: 250.0605 (M + H)+, found: 250.0608. 
4.3.9. (-)-Ethyl-2-(p-toluidino)propionate 3i. Yield: 98%; 1H NMR (CDCl3): į = 1.27 (t, 
3H), 1.49 (d,3H), 2.26 (s, 3H), 4.12 (q, 1H), 4.4.20 (q, 2H), 6.61 (d, 2H), 7.01 (d, 2H); 13C 
NMR (CDCl3): 14.19, 18.81, 20.43, 52.74, 61.10, 114.09, 129.81, 174.48; [Į]20D = -17.0 (c 
1.5, CHCl3); ee = 31% (HPLC conditions: Chiralpak AS-H column, hexane/i-PrOH : 99/1, 
flow rate = 0.5 ml/min, wavelength = 220 nm, tR = 12.78 min for minor isomer , tR = 14.77 
min for major isomer). HRESIMS (m/z) calculated for C12H18NO2: 208.1332 (M + H)+, 
found: 208.1330. 
4.3.10. (-)-Ethyl-2-(p-chlorophenylamino)propionate 3j. Yield: 99%; 1H NMR (CDCl3): į
= 1.27 (t, 3H), 1.47 (d, 3H), 4.08 (q, 1H),  4.20 (q, 2H), 6.54 (d, 2H), 7.12 (d, 2H); 13C NMR 
(CDCl3): 14.18, 18.77, 52.11, 61.25, 114.51, 122.86, 129.14, 145.24, 174.32; [Į]20D = -26.1 (c 
2.5,  CHCl3); ee = 48% (HPLC conditions: Chiralpak AS-H column, hexane/i-PrOH : 99/1, 
flow rate = 0.5 ml/min, wavelength = 220 nm, tR = 32.79 min for minor isomer , tR = 37.86 
min for major isomer). HRESIMS (m/z) calculated for C11H15ClNO2: 250.0605 (M + H)+, 
found: 250.0608. 
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4.3.11. (-)-t-Bu-2-(phenylamino)propionate  3k. Yield: 75%; 1H NMR (CDCl3): į = 1.46 (s, 
9H), 1.47 (d, 3H), 4.05 (q, 1H), 6.66 (d, 2H), 6.76 (t, 1H), 7.20 (t, 2H); 13C NMR (CDCl3): 
18.82, 27.98, 52.74, 81.50, 113.66, 118.28, 129.25, 146.59, 173.72; [Į]20D = -26.6 (c 2.0, 
CHCl3); ee = 53% (HPLC conditions: Chiralcel OJ-H column, hexane/i-PrOH : 99/1, flow 
rate = 0.5 ml/min, wavelength = 220 nm, tR = 25.07 min for minor isomer , tR = 27.26 min for 
major isomer). HRESIMS (m/z) calculated for C13H19NO2Na: 244.1313 (M + Na)+, found: 
244.1314. 
4.3.12. (-)-t-Bu-2-( o-toluidino)propionate  3l. Yield: 72%; 1H NMR (CDCl3): į = 1.47 (s, 
9H), 1.50 (d, 3H), 2.22 (s, 3H), 4.09 (q, 1H), 6.56 (d, 1H), 6.69 (t, 1H), 7.10 (m, 2H); 13C 
NMR (CDCl3): 17.48, 19.09, 28.00, 52.51, 81.47, 110.32, 117.60, 122.56,  127.01, 130.31, 
144.86, 173.99; [Į]20D = -15.3 (c 3.0, CHCl3); ee = 56% (GC conditions: CP-Chirasil-Dex 
column, 80°C (1 min), 1°C min-1 80-180°C, tR = 50.15 min for minor isomer , tR = 50.50 min 
for major isomer). HRESIMS (m/z) calculated for C14H21NO2Na: 258.1470 (M + Na)+, found: 
258.1469. 
 4.313. (-)-t-Bu-2-( m-toluidino)propionate  3m. Yield: 67%; 1H NMR (CDCl3): į = 1.45 (d, 
3H), 1.47 (s, 9H), 2.29 (s,3H), 4.04 (q, 1H), 6.44 (d, 1H), 6.46 (s, 1H), 6.57 (d, 1H), 7.08 (t, 
1H); 13C NMR (CDCl3): 18.92, 21.59,  27.99, 52.57, 81.38, 110.56, 114.28, 118.99, 129.10, 
138.98, 146.83, 174.01; [Į]20D = -22.0  (c 1.4, CHCl3); ee = 44% (HPLC conditions: Chiralcel 
OJ-H column, hexane/i-PrOH : 99/1, flow rate = 0.5 ml/min, wavelength = 220 nm, tR = 18.82 
min for minor isomer , tR = 21.43 min for major isomer). HRESIMS (m/z) calculated for 
C14H22NO2: 236.1651 (M + H)+, found: 236.1651. 
 4.3.14. (-)-t-Bu-2-( p-toluidino)propionate  3n. Yield: 81%; 1H NMR (CDCl3): į = 1.45 (d, 
3H), 1.46 (s, 9H), 2.26 (s,3H), 4.01 (q, 1H), 6.58 (d, 2H), 7.01 (d, 2H); 13C NMR (CDCl3): 
18.84, 20.42,  27.99, 53.10, 81.39, 113.91,127.55, 129.74, 144.25, 173.87; [Į]20D = -17.5 (c 
1.8, CHCl3); ee = 47% (HPLC conditions: Chiralcel OD-H column, hexane/i-PrOH : 99/1, 
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flow rate = 0.3 ml/min, wavelength = 220 nm, tR = 17.10 min for minor isomer , tR = 20.22 
min for major isomer). HRESIMS (m/z) calculated for C14H22NO2: 236.1651 (M + H)+, 
found: 236.1651. 
 4.3.15. (-)-t-Bu-2-( o-chlorophenylamino)propionate 3o. Yield: 76%; 1H NMR (CDCl3): į
= 1.46 (s, 9H), 1.51 (d, 3H),  4.07 (q, 1H), 6.61 (d, 1H), 6.67 (t, 1H), 7.13 (t, 1H), 7.28 (d, 
1H); 13C NMR (CDCl3): 18.74,  27.95, 52.46, 81.70, 111.72, 115.87, 117.92, 127.68, 129.35, 
142.84, 173.12; [Į]20D = -8.3 (c 1.8, CHCl3); ee = 67% (HPLC conditions: Chiralcel OJ-H 
column, hexane/i-PrOH : 99/1, flow rate = 0.1 ml/min, wavelength = 220 nm, tR = 58.82 min 
for major isomer , tR = 65.04 min for minor isomer). HRESIMS (m/z) calculated for 
C13H18NO2ClNa: 278.0923 (M + Na)+, found: 278.0924. 
4.3.16. (-)-t-Bu-2-( m-chlorophenylamino)propionate 3p. Yield: 77%; 1H NMR (CDCl3): į
= 1.45 (d, 3H), 1.47 (s, 9H),  4.00 (q, 1H), 6.50 (d, 1H), 6.61 (s, 1H), 6.71 (d, 1H), 7.13 (t, 
1H), 7.09 (t, 1H); 13C NMR (CDCl3): 18.63,  27.97, 52.46, 81.85, 111.90, 113.19, 118.05, 
130.22, 135.00, 147.73, 173.27; [Į]20D = -26.0 (c 2.1, CHCl3); ee = 66% (HPLC conditions: 
Chiralcel OJ-H column, hexane/i-PrOH : 99/1, flow rate = 0.2 ml/min, wavelength = 220 nm, 
tR = 49.19 min for minor isomer , tR = 54.33 min for major isomer). HRESIMS (m/z) 
calculated for C13H18NO2ClNa: 278.0923 (M + Na)+, found: 278.0924. 
4.3.17. (-)-t-Bu-2-( p-chlorophenylamino)propionate 3q Yield: 80%; 1H NMR (CDCl3): į = 
1.44 (d, 3H), 1.46 (s, 9H),  3.98 (q, 1H), 6.54 (d, 2H), 7.13 (d, 2H); 13C NMR (CDCl3): 18.73,  
27.98, 52.64, 81.69, 114.50, 122.64, 129.09, 138.98, 145.42, 173.51; [Į]20D = -25.6 (c 2.1, 
CHCl3); ee = 55% (HPLC conditions: Chiralcel OJ-H column, hexane/i-PrOH : 99/1, flow 
rate = 0.5 ml/min, wavelength = 220 nm, tR = 26.37 min for minor isomer , tR = 28.06 min for 
major isomer). HRESIMS (m/z) calculated for C13H18NO2ClNa: 278.0923 (M + Na)+, found: 
278.0924. 
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4.3.18. (-)-Benzyl-2-(phenylamino)propionate 3r. Yield: 98%; 1H NMR (CDCl3): į = 1.52 
(d, 3H), 4.24 (q, 1H), 5.20 (s, 2H), 6.65 (d, 1H), 6.79 (t, 1H), 7.21 (t, 2H), 7.31-7.41 (m, 5H); 
13C NMR (CDCl3): 18.92, 52.14, 66.86, 113.52, 118.44, 128.16, 128.36, 128.60, 129.36, 
135.59, 146.57, 174.49; [Į]20D = -16.2 (c 2.4, CHCl3); ee = 81% (HPLC conditions: Chiralcel 
OB-H column, hexane/i-PrOH : 99/1, flow rate = 0.5 ml/min, wavelength = 220 nm, tR =
30.14 min for major isomer , tR = 42.30 min for minor isomer). HRESIMS (m/z) calculated 
for C16H17NO2Na: 278.1157 (M + Na)+, found: 278.1156. 
4.3.19. (-)-Benzyl-2-(o-chlorophenylamino)propionate 3s. Yield: 98%; 1H NMR (CDCl3): į
= 1.57 (d, 3H), 4.25 (q, 1H), 5.21 (s, 2H), 6.59 (d, 1H), 6.67 (t, 1H), 7.11 (t, 1H), 7.28-7.40 
(m, 5H); 13C NMR (CDCl3): 18.75, 51.90, 51.93, 66.98, 111.73, 118.28, 119.75, 127.79,  
128.15, 128.39, 128.60, 129.43, 133.50, 142.55, 173.77; [Į]20D = -4.8 (c 2.7, CHCl3); ee = 
81% (HPLC conditions: Chiralcel OB-H column, hexane/i-PrOH : 99/1, flow rate = 0.5 
ml/min, wavelength = 220 nm, tR = 30.14 min for major isomer , tR = 42.30 min for minor 
isomer). HRESIMS (m/z) calculated for C16H16ClNO2Na: 312.0767 (M + Na)+, found: 
312.0766. 
  4.3.20. (+)-Benzyl-2-(o-bromophenylamino)propionate 3t. Yield: 97%; 1H NMR 
(CDCl3): į =  1.58 (d,3H), 4.25 (q, 1H), 5.21 (s,1H), 6.57 (d, 1H), 6.63 (t, 1H), 7.15 (t, 1H), 
7.32-7.48 (m, 5H); 13C NMR (CDCl3): 18.75, 52.09, 66.98, 110.23, 111.17, 118.77, 128.16, 
128.39, 128.49, 128.61, 132.72, 135.50,  143.56, 173.72; [Į]20D = +4.8 (c 3.1, CHCl3); ee = 
73% (HPLC conditions: Chiralcel OB-H column, hexane/i-PrOH : 99/1, flow rate = 0.5 
ml/min, wavelength = 220 nm, tR = 32.11 min for major isomer , tR = 44.00 min for minor 
isomer). HRESIMS (m/z) calculated for C16H16BrNO2Na: 356.0262(M + Na)+, found: 
356.0266. 
4.3.21. (+)-Ethyl-2-phenyl-2-(o-chlorophenylamino)acetate 3u. Yield: 84%; 1H NMR 
(CDCl3): į = 1.25 (t, 3H), 4.17-4.30 (m, 3H), 6.41 (d, 1H), 6.65 (t, 1H), 7.03 (t, 1H), 7.29-
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7.41 (m, 4H), 7.53 (d, 2H); 13C NMR (CDCl3): 14.02, 29.72, 60.58, 61.99, 112.12, 118.00, 
119.67, 127.12, 127.64, 128.38, 128.90, 129.25, 137.15, 141.95, 171.19; [Į]20D = +7.0 (c 2.3, 
CHCl3); ee = 50%  (HPLC conditions: Chiralcel OJ-H column, hexane/i-PrOH : 99/1, flow 
rate = 0.3 ml/min, wavelength = 220 nm, tR = 36.14 min for minor isomer , tR = 40.12 min for 
major isomer). HRESIMS (m/z) calculated for C16H16NO2ClNa: 312.0767 (M + Na)+, found: 
312.0766. 
4.3.22. (+)-Ethyl-2-(naphtylamino)propionate 3w. Yield: 85%; 1H NMR (CDCl3): į = 1.31 
(t, 3H), 1.64 (d, 3H), 4.26 (q, 2H),  4.34 (q, 1H), 6.58 (d, 2H), 7.28-7.37 (m, 2H), 7.47-7.51 
(m, 2H), 7.80-7.83 (m, 1H), 7.92-7.96 (m, 1H); 13C NMR (CDCl3): 14.22, 18.89, 52.15, 
61.28, 105.15, 118.31, 120.14, 123.72, 124.91, 125.85, 126.36, 128.62, 134.43,  141.83, 
174.67; [Į]20D = +18 (c 1.2,  CHCl3); ee = 43% (HPLC conditions: Chiralpak OJ-H column, 
hexane/i-PrOH : 99/1, flow rate = 1.0 ml/min, wavelength = 220 nm, tR = 27.56 min for minor 
isomer , tR = 33.88 min for major isomer). HRESIMS (m/z) calculated for C15H18NO2: 
244.1338 (M + H)+, found: 244.1336. 
Legends 
Fig.1. Structures of chiral bisoxazoline ligands 
Fig. 2. ESI-MS analysis of the solution of [CuL*] formed by CuOTf and L*(1:1 molar ratio) 
in CH2Cl2
Scheme 1. Proposed mechanism for copper-catalyzed N-H insertion 
Table 1. Cu-catalyzed asymmetric insertion of ethyl Į-diazopropionate into N-H bond of o-Cl 
aniline 
Table 2. Catalytic asymmetric N-H insertion of amines with Į-diazoesters 
Table 3. Catalytic asymmetric N-H insertion of arylamines with ethyl Į-diazopropionate with 
different ligands 
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ϮϬ͘ DŽŽĚǇ͕͘:͖͘dĂǇůŽƌ͕Z͘:͘dĞƚƌĂŚĞĚƌŽŶ>Ğƚƚ͘ϭϵϴϳ͕Ϯϴ͕ϱϯϱϭͲϱϯϱϮ͘
Ϯϭ͘ 'ŽƚŽ͕d͖͘dĂŬĞĚĂ͕<͖͘^ŚŝŵĂĚĂ͕E͖͘EĂŵďƵ͕,͖͘ŶĂĚĂ͕D͖͘^ŚŝƌŽ͕D͖͘ŶĚŽ͕<͖͘,ĂƐŚŝŵŽƚŽ͕^͘
ŶŐĞǁ͘ŚĞŵ͘/Ŷƚ͘Ě͘ϮϬϭϭ͕ϱϬ͕ϲϴϬϯͲϲϴϬϴ͘
ϮϮ͘ >ŝƵ͕͖͘ŚƵ͕^͘Ͳ&͖͘ŚĂŶŐ͕t͖͘ŚĞŶ͕͖͘ŚŽƵ͕Y͘Ͳ>͘:͘ŵ͘ŚĞŵ͘^ŽĐ͘ϮϬϬϳ͕ϭϮϵ͕ϱϴϯϰͲϱϴϯϱ͘
Ϯϯ͘ ŚƵ͕^͘Ͳ&͖͘yƵ͕͖͘tĂŶŐ͕'͘ͲW͖͘ŚŽƵ͕Y͘Ͳ>͘:͘ŵ͘ŚĞŵ͘^ŽĐ͘ϮϬϭϮ͕ϭϯϰ͕ϰϯϲͲϰϰϮ͘
Ϯϰ͘ ŚĂŽ͕y͖͘ŚĂŶŐ͕z͖͘tĂŶŐ͕:͘ŚĞŵ͘ŽŵŵƵŶ͘ϮϬϭϮ͕ϰϴ͕ϭϬϭϲϮͲϭϬϭϳϯ͘
Ϯϱ͘ ,ŽƵ͕͖͘tĂŶŐ͕:͖͘,Ğ͕W͖͘tĂŶŐ͕:͖͘YŝŶ͕͖͘>ŝƵ͕y͖͘>ŝŶ͕>͖͘&ĞŶŐ͕y͘ŶŐĞǁ͘ŚĞŵ͘/Ŷƚ͘Ě͘ϮϬϭϬ͕
ϰϵ͕ϰϳϲϯͲϰϳϲϲ͘
Ϯϲ͘ 'ĂůĂƌĚŽŶ͕͖͘>ĞDĂƵǆ͕W͖͘^ŝŵŽŶŶĞĂƵǆ͕'͘:͘ŚĞŵ͘^ŽĐ͕͘WĞƌŬŝŶƐdƌĂŶƐ͘ϭϭϵϵϳ͕ϮϰϱϱͲϮϰϱϲ͘
Ϯϳ͘ 'ĂůĂƌĚŽŶ͕͖͘>ĞDĂƵǆ͕W͖͘^ŝŵŽŶŶĞĂƵǆ͕'͘dĞƚƌĂŚĞĚƌŽŶϮϬϬϬ͕ϱϲ͕ϲϭϱͲϲϮϭ͘
Ϯϴ͘ dĂŬĂĐƐ͕:͘D͖͘YƵŝŶĐǇ͕͘͖͘^ŚĂǇ͕t͖͘:ŽŶĞƐ͕͘͖͘ZŽƐƐ/ŝ͕͘Z͘dĞƚƌĂŚĞĚƌŽŶ͗ƐǇŵŵĞƚƌǇ
ϭϵϵϳ͕ϴ͕ϯϬϳϵͲϯϬϴϳ͘
Ϯϵ͘ >ĞDĂƵǆ͕W͖͘ŽƌĐĞƚ͕s͖͘^ŝŵŽŶŶĞĂƵǆ͕'͘dĞƚƌĂŚĞĚƌŽŶϮϬϭϯ͕ϲϵ͕ϴϮϵϭͲϴϮϵϴ͘
ϯϬ͘ ,ĂƐŚŝŵŽƚŽ͕d͖͘EĂŐĂŶĂǁĂ͕z͖͘DĂƌƵŽŬĂ͕<͘:͘ŵ͘ŚĞŵ͘^ŽĐ͘ϮϬϭϭ͕ϭϯϯ͕ϴϴϯϰͲϴϴϯϳ͘
ϯϭ͘ KƐĂŬŽ͕d͖͘WĂŶŝĐŚĂŬƵů͕͖͘hŽǌƵŵŝ͕z͘KƌŐ͘>Ğƚƚ͘ϮϬϭϮ͕ϭϰ͕ϭϵϰͲϭϵϳ͘
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